BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 1627924)

  • 21. Endocrine changes in the late-follicular and postovulatory intervals as determinants of the in vitro fertilization pregnancy rate.
    Zarutskie PW; Kuzan FB; Dixon L; Soules MR
    Fertil Steril; 1987 Jan; 47(1):137-43. PubMed ID: 3098584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.
    Lindheim SR; Chang PL; Vidali A; Ferin M; Sauer MV
    J Assist Reprod Genet; 1998 Oct; 15(9):538-41. PubMed ID: 9822981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.
    Fanchin R; de Ziegler D; Taieb J; Hazout A; Frydman R
    Fertil Steril; 1993 May; 59(5):1090-4. PubMed ID: 8486179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.
    Muasher SJ; Oehninger S; Simonetti S; Matta J; Ellis LM; Liu HC; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Aug; 50(2):298-307. PubMed ID: 3135206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing pregnancies after follicular stimulation for IVF with clomiphene citrate and human menopausal gonadotrophin only.
    Fishel SB; Webster J; Faratian B; Jackson P; Shelton K; Johnson J
    Hum Reprod; 1991 Jan; 6(1):106-12. PubMed ID: 1908488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro fertilization: diurnal and seasonal variation in luteinizing hormone surge onset and pregnancy rates.
    Casper RF; Erskine HJ; Armstrong DT; Brown SE; Daniel SA; Graves GR; Yuzpe AA
    Fertil Steril; 1988 Apr; 49(4):644-8. PubMed ID: 3127247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of a spontaneous luteinizing hormone surge in superovulated cycles--predictive value of serum progesterone.
    Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
    Fertil Steril; 1988 Jan; 49(1):86-9. PubMed ID: 3121400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High preovulatory serum luteinizing hormone level is unfavorable to conception.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Papp Z; Runnebaum B
    Gynecol Endocrinol; 1991 Dec; 5(4):223-33. PubMed ID: 1796745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
    Givens CR; Schriock ED; Dandekar PV; Martin MC
    Fertil Steril; 1994 Nov; 62(5):1011-7. PubMed ID: 7926111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
    Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
    Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Superovulation-induced transient hyperprolactinemia in human in vitro fertilization and embryo transfer].
    Oda T; Yoshimura S; Hara T; Hara S; Yahagi M; Matsumoto C; Ohno T; Nakamura Y; Sumi Y; Sueoka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):113-20. PubMed ID: 3102646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acupuncture combined with medication improves endocrine hormone levels and ovarian reserve function in poor ovarian response patients undergoing in vitro fertilization-embryo transplantation].
    Dong XL; Ran JK; Zhang HJ; Chen K; Li HX
    Zhen Ci Yan Jiu; 2019 Aug; 44(8):599-604. PubMed ID: 31475495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro fertilization cycles.
    Dlugi AM; Laufer N; Decherney AH; Polan ML; Haseltine FP; Tarlatzis BC; Graebe RA; Barnea ER; Naftolin F
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):33-40. PubMed ID: 3926922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of human chorionic gonadotropin for in vitro fertilization-embryo transfer based on the serum luteinizing hormone (LH) concentration: the importance of synchronization with endogenous LH rises.
    Jinno M; Ubukata Y; Hanyu I; Satou M; Yoshimura Y; Nakamura Y
    Fertil Steril; 1995 Apr; 63(4):859-65. PubMed ID: 7890075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program.
    Weisman Z; Dirnfeld M; Lissak A; Sorokin Y; Abramovici H
    Fertil Steril; 1989 Sep; 52(3):451-3. PubMed ID: 2506078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.